IP Library › Granted Patent US 9,457,088
Granted Patent B2
US 9,457,088 · App. 13/774,159 · Granted Oct 4, 2016

Topical compositions comprising fipronil and permethrin and methods of use

Inventors: Mark David Soll (Alpharetta, GA); James Pate (Hampton, NJ); Lisa A. Baker (Somerset, NJ)
Assignee: MERIAL, INC.
A61K47/22A01N47/02A01N53/00A61K9/0017A61K31/215A61K31/415A61K45/06A61K47/08A61K47/14A61K47/18
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,457,088
App. No.
13/774,159
Granted
Oct 4, 2016
Kind
B2
Abstract

The subject matter disclosed herein is directed to stable, highly-effective topical formulations comprising permethrin, fipronil and a solvent system that is sufficient to solubilize these two active ingredients and limit degradation of fipronil to its sulfone, and their uses in topical applications on animals and the environment. Useful formulations comprise from about 30% to about 55% (w/w) permethrin and about 2 to 15% (w/w) fipronil and a solvent system that comprises N-methyl pyrrolidone and a glycol, glycol ether, glycol ester, fatty acid ester or neutral oil, wherein the N-methyl pyrrolidone and glycol, glycol ether, glycol ester, fatty acid ester or neutral oil are present in a weight:weight ratio of from about 1:2.0 to about 1:3.5, glycol, glycol ether, glycol ester, fatty acid ester or neutral oil to n-methyl pyrrolidone. These two actives when combined in the described amounts have been found to have unexpected enhanced repellent activity against stable fly. However, it is the formulations described herein that provide solvency and stability that maintain synergistic concentrations after application on an animal.

Claims (33)

1. A topical composition in the form of a solution for the treatment and prevention of an ectoparasitic infestation comprising:

from about 2% (w/w) to about 15% (w/w) fipronil;

from about 30% (w/w) to about 55% (w/w) permethrin; and

a neutral oil and N-methyl pyrrolidone, wherein said neutral oil is a triglyceride of C8 to C10 fatty acids; and wherein said neutral oil and N-methyl pyrrolidone are present in a weight:weight ratio of from about 1:2.0 to about 1:3.0, neutral oil to N-methyl pyrrolidone, wherein the term about encompasses variations of ±5%, from the specified amount.

2. The composition of claim 1 , wherein said fipronil is present in a concentration of from about 4% (w/w) to about 8% (w/w).

3. The composition of claim 1 , wherein said fipronil is present at a concentration of about 6% (w/w).

4. The composition of claim 1 , wherein said permethrin is present in a concentration of from about 35% (w/w) to about 50% (w/w).

5. The composition of claim 1 , wherein said permethrin is present in a concentration of from about 40% (w/w) to about 48% (w/w).

6. The composition of claim 1 , wherein said permethrin is present at a concentration of about 45% (w/w).

7. The composition of claim 1 , wherein said fipronil is present at a concentration of about 6.0% (w/w) and said permethrin is present at a concentration of about 45% (w/w).

8. The composition of claim 1 , wherein said neutral oil is present in a concentration of about 12% (w/w) to about 14% (w/w) and said N-methyl pyrrolidone is present in a concentration of about 35% (w/w).

9. The composition of claim 1 , wherein said neutral oil and said N-methyl pyrrolidone are present in a weight:weight ratio of about 1:2.5 to about 1:3.0, neutral oil to N-methyl pyrrolidone.

10. The composition of claim 1 , wherein said neutral oil and said N-methyl pyrrolidone are present in a weight:weight ratio of about 1:2.2 to about 1:2.4, neutral oil to N-methyl pyrrolidone.

11. The composition of claim 1 , wherein said neutral oil and said N-methyl pyrrolidone are present in a weight:weight ratio of about 1:2.5 to about 1:2.8, neutral oil to N-methyl pyrrolidone.

12. The composition of claim 1 , wherein said neutral oil is a triglyceride of caprylic/capric fatty acids.

13. The composition of claim 1 , comprising

about 6% (w/w) fipronil;

about 45% (w/w) permethrin;

about 12% to about 14% (w/w) of triglycerides of fractionated plant fatty acids having chain lengths of C8 and C10;

about 35% (w/w) N-methyl pyrrolidone; and

about 0.1% (w/w) butylated hydroxytoluene.

14. The composition of claim 1 , further comprising an antioxidant.

15. The composition of claim 14 , wherein said antioxidant is butylated hydroxytoluene.

16. The composition of claim 1 further comprising one or more additional active agents.

17. The composition of claim 16 , wherein the one or more additional active agent is an avermectin, a milbemycin, a spinosyn, a spinosoid, a benzimidazole, levamisole, pyrantel, morantel, praziquantel, closantel, clorsulon, an amino acetonitrile active agent, an insect growth regulator, a neonicotinoids or an aryloazol-2-yl cyanoethylamino active agent, or a combination of thereof.

18. A spot-on composition in the form of a solution, comprising from about 2% (w/w) to about 15% (w/w) fipronil;

from about 30% (w/w) to about 55% (w/w) permethrin; and

a neutral oil and N-methyl pyrrolidone, wherein said neutral oil is a triglyceride of C8 to C10 fatty acids; said neutral oil and N-methyl pyrrolidone are present in a weight:weight ratio of from about 1:2.0 to about 1:3.0, wherein said composition is a liquid having a volume of from about 1 mL to about 10 mL, wherein the term about encompasses variations of ±5%, from the specified amount.

19. The composition of claim 1 or 18 , further comprising fipronil sulfone below about 3.5% by area relative to the peak area for fipronil as measured by HPLC at about three months after formulation.

20. The composition of claim 1 or 18 , further comprising fipronil sulfone wherein said amount of fipronil sulfone at about three months after formulation has not increased by more than 50% of the original amount of said fipronil sulfone present at the time of formulation.

21. A method for the treatment and/or protection of a parasite infestation in an animal, comprising administering an effective amount of the composition of claim 1 to the animal.

22. The method of claim 21 , wherein said administering comprises contacting the coat and/or skin of said animal with said composition.

23. The composition of claim 18 , wherein the neutral oil is a triglyceride of caprylic/capric fatty acids.

Assignments (3)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 17, 2020
From: MERIAL, INC.
To: BOEHRINGER INGELHEIM ANIMAL HEALTH USA INC.
Reel/Frame 051627/0283 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 7, 2016
From: MERIAL LIMITED
To: MERIAL, INC.
Reel/Frame 038021/0025 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 3, 2013
From: SOLL, MARK DAVID; PATE, JAMES; BAKER, LISA
To: MERIAL LIMITED
Reel/Frame 030143/0698 →
Continuity (2)
Provisional Application 61602472 · Feb 23, 2012
Related Publication 20130225516A1 · Aug 29, 2013